Early 2016/17 vaccine effectiveness estimates against influenza A(H3N2): I-MOVE multicentre case control studies at primary care and hospital levels in Europe

被引：49

作者：

Kissling, E. ^{[1
]}

Rondy, M. ^{[1
]}

机构：

[1] EpiConcept, Paris, France

来源：

EUROSURVEILLANCE | 2017年 / 22卷 / 07期

基金：

欧盟地平线“2020”;

关键词：

SEASON; A(H1N1)PDM09;

D O I：

10.2807/1560-7917.ES.2017.22.7.30464

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

We measured early 2016/17 season influenza vaccine effectiveness (IVE) against influenza A(H3N2) in Europe using multicentre case control studies at primary care and hospital levels. IVE at primary care level was 44.1%, 46.9% and 23.4% among 0-14, 15-64 and >= 65 year-olds, and 25.7% in the influenza vaccination target group. At hospital level, IVE was 2.5%, 7.9% and 2.4% among >= 65, 65-79 and >= 80 year-olds. As in previous seasons, we observed suboptimal IVE against influenza A(H3N2).

引用

页码：2 / 10

页数：9

共 36 条

[1] Early estimates of seasonal influenza vaccine effectiveness in Europe, 2010/11: I-MOVE, a multicentre case-control study
Kissling, E.
Valenciano, M.
[J]. EUROSURVEILLANCE, 2011, 16 (11): : 11 - 15
[2] Early estimates of seasonal influenza vaccine effectiveness in Europe: results from the I-move multicentre case-control study, 2012/13
Valenciano, M.
Kissling, E.
[J]. EUROSURVEILLANCE, 2013, 18 (07): : 12 - 17
[3] Influenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021-2022 I-MOVE primary care multicentre study
Kissling, Esther
Pozo, Francisco
Martinez-Baz, Ivan
Buda, Silke
Vilcu, Ana-Maria
Domegan, Lisa
Mazagatos, Clara
Dijkstra, Frederika
Latorre-Margalef, Neus
Filipovic, Sanja Kurecic
Machado, Ausenda
Lazar, Mihaela
Casado, Itziar
Duerrwald, Ralf
van der Werf, Sylvie
O'Donnell, Joan
Dopido, Juan Antonio Linares
Meijer, Adam
Riess, Maximilian
Vucina, Vesna Visekruna
Rodrigues, Ana Paula
Mihai, Maria Elena
Castilla, Jesus
Goerlitz, Luise
Falchi, Alessandra
Connell, Jeff
Castrillejo, Daniel
Hooiveld, Mariette
Carnahan, Annasara
Ilic, Maja
Guiomar, Raquel
Ivanciuc, Alina
Maurel, Marine
Omokanye, Ajibola
Valenciano, Marta
Mlinaric, Ivan
Kaic, Bernard
Ferencak, Ivana
Adamic, Katica Cusek
Licina, Mirjana Lana Kosanovic
Lakoseljac, Danijela
Huskic, Ivana Mihin
Nonkovic, Diana
Blanchon, Thierry
Guerrisi, Caroline
Launay, Titouan
Benamar, Hayat
Sevila, Julie
Masse, Shirley
Behillil, Sylvie
[J]. INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2023, 17 (01)
[4] Estimates of Pandemic Influenza Vaccine Effectiveness in Europe, 2009-2010: Results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) Multicentre Case-Control Study
Valenciano, Marta
Kissling, Esther
Cohen, Jean-Marie
Oroszi, Beatrix
Barret, Anne-Sophie
Rizzo, Caterina
Nunes, Baltazar
Pitigoi, Daniela
Larrauri Camara, Amparro
Mosnier, Anne
Horvath, Judith K.
O'Donnell, Joan
Bella, Antonino
Guiomar, Raquel
Lupulescu, Emilia
Savulescu, Camelia
Ciancio, Bruno C.
Kramarz, Piotr
Moren, Alain
[J]. PLOS MEDICINE, 2011, 8 (01)
[5] Interim estimates of 2016/17 vaccine effectiveness against influenza A(H3N2), Canada, January 2017
Skowronski, D. M.
Chambers, C.
Sabaiduc, S.
Dickinson, J. A.
Winter, A.
De Serres, G.
Drews, S. J.
Jassem, A.
Gubbay, J. B.
Charest, H.
Balshaw, R.
Bastien, N.
Li, Y.
Krajden, M.
[J]. EUROSURVEILLANCE, 2017, 22 (06): : 2 - 9
[6] 2015/16 I-MOVE/I-MOVE plus multicentre case-control study in Europe: Moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage-mismatched influenza B among children
Kissling, Esther
Valenciano, Marta
Pozo, Francisco
Vilcu, Ana-Maria
Reuss, Annicka
Rizzo, Caterina
Larrauri, Amparo
Horvath, Judit Krisztina
Brytting, Mia
Domegan, Lisa
Korczynska, Monika
Meijer, Adam
Machado, Ausenda
Ivanciuc, Alina
Vucina, Vesna Visekruna
van der Werf, Sylvie
Schweiger, Brunhilde
Bella, Antonino
Gherasim, Alin
Ferenczi, Annamaria
Zakikhany, Katherina
O'Donnell, Joan
Paradowska-Stankiewicz, Iwona
Dijkstra, Frederika
Guiomar, Raquel
Lazar, Mihaela
Filipovic, Sanja Kurecic
Johansen, Kari
Moren, Alain
[J]. INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2018, 12 (04) : 423 - 437
[7] Early influenza vaccine effectiveness results 2015-16: I-MOVE multicentre case-control study
Kissling, E.
Valenciano, M.
[J]. EUROSURVEILLANCE, 2016, 21 (06): : 18 - 18
[8] Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13
Kissling, E.
Valenciano, M.
Buchholz, U.
Larrauri, A.
Cohen, J. M.
Nunes, B.
Rogalska, J.
Pitigoi, D.
Paradowska-Stankiewicz, I.
Reuss, A.
Jimenez-Jorge, S.
Daviaud, I.
Guiomar, R.
O'Donnell, J.
Necula, G.
Gluchowska, M.
Moren, A.
[J]. EUROSURVEILLANCE, 2014, 19 (06): : 22 - 33
[9] Early estimates of seasonal influenza vaccine effectiveness in Europe among target groups for vaccination: results from the I-MOVE multicentre case-control study, 2011/12
Kissling, E.
Valenciano, M.
[J]. EUROSURVEILLANCE, 2012, 17 (15): : 6 - 12
[10] Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15
Valenciano, M.
Kissling, E.
Reuss, A.
Rizzo, C.
Gherasim, A.
Horvath, J. K.
Domegan, L.
Pitigoi, D.
Machado, A.
Paradowska-Stankiewicz, I. A.
Bella, A.
Larrauri, A.
Ferenczi, A.
O'Donell, Joan
Lazar, M.
Pechirra, P.
Korczynska, M. R.
Pozo, F.
Moren, A.
[J]. EUROSURVEILLANCE, 2016, 21 (07) : 15 - 31

← 1 2 3 4 →